…
DSwiss, Inc., a biotech nutraceutical company, provides healthcare, skincare, and personal care products in Malaysia, Singapore, Indonesia, Australia, Hong Kong, Taiwan, Macau, and China. It supplies health and beauty products, including weight management beverages, anti-aging creams, and immune system enhancers. The company also provides private label manufacturing services for nutraceutical and skincare/personal care ODM/OEM products; pet wellness supplements; and pet-care products, as well as medical consumable supplies, such as disposable stretcher cover and bedsheet, masks, body infrared thermometers, sanitizer, protective goggles, surgical gloves, isolation suit, industrial disinfectant, and protection surgical and medical gown. In addition, it offers OEM/ODM/OBM services, such as DSwiss quantum magnetic analyzer and DNA genotyping services; Eyecare; and biotechnology research channel services. DSwiss, Inc. was incorporated in 2015 and is headquartered in Kuala Lumpur, Malaysia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -0.06M | 0.03M | -0.05M | -0.00M | 0.15M |
| Minority interest | - | - | -0.02M | -0.01M | 0.02M |
| Net income | -0.08M | 0.02M | -0.05M | -0.01M | 0.17M |
| Selling general administrative | 0.65M | 0.60M | 0.41M | 0.44M | 0.35M |
| Selling and marketing expenses | - | - | 0.04M | - | - |
| Gross profit | 0.56M | 0.62M | 0.36M | 0.44M | 0.50M |
| Reconciled depreciation | 0.06M | 0.02M | 0.07M | 0.07M | 0.07M |
| Ebit | -0.05M | 0.03M | -0.05M | 0.00M | 0.15M |
| Ebitda | 0.02M | 0.05M | 0.02M | 0.08M | 0.22M |
| Depreciation and amortization | 0.06M | 0.02M | 0.07M | 0.07M | 0.07M |
| Operating income | -0.09M | 0.02M | -0.05M | 0.00M | 0.15M |
| Other operating expenses | 3.01M | 3.09M | 1.52M | 1.85M | 1.81M |
| Interest expense | 0.01M | 0.00M | 0.00M | 0.01M | 0.00M |
| Tax provision | 0.02M | 0.01M | 0.00M | 0.00M | 0.00M |
| Net interest income | -0.01M | -0.00M | -0.00M | -0.01M | -0.00M |
| Income tax expense | 0.02M | 0.01M | 0.00M | 0.00M | 0.00M |
| Total revenue | 2.92M | 3.11M | 1.47M | 1.85M | 1.96M |
| Total operating expenses | 0.65M | 0.60M | 0.37M | 0.45M | 0.35M |
| Cost of revenue | 2.36M | 2.49M | 1.11M | 1.40M | 1.46M |
| Total other income expense net | 0.02M | 0.01M | 0.00M | -0.01M | -0.00M |
| Net income from continuing ops | -0.08M | 0.02M | -0.12M | -0.00M | 0.15M |
| Net income applicable to common shares | - | - | - | - | 0.17M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 0.68M | 0.64M | 0.37M | 0.38M | 0.50M |
| Intangible assets | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Other current assets | 0.03M | 0.02M | 0.02M | 0.02M | 0.05M |
| Total liab | 0.69M | 0.56M | 0.31M | 0.28M | 0.42M |
| Total stockholder equity | -0.01M | 0.07M | 0.06M | 0.09M | 0.07M |
| Other current liab | 0.29M | 0.30M | 0.17M | 0.15M | 0.25M |
| Common stock | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M |
| Capital stock | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M |
| Retained earnings | -1.46M | -1.39M | -1.41M | -1.32M | -1.31M |
| Cash | 0.29M | 0.40M | 0.25M | 0.21M | 0.23M |
| Total current liabilities | 0.47M | 0.48M | 0.30M | 0.25M | 0.32M |
| Net debt | -0.00M | -0.29M | -0.21M | -0.11M | -0.07M |
| Short term debt | 0.06M | 0.03M | 0.02M | 0.06M | 0.06M |
| Short long term debt total | 0.28M | 0.11M | 0.04M | 0.10M | 0.17M |
| Other stockholder equity | 1.40M | 1.40M | 1.40M | 1.40M | 1.40M |
| Property plant equipment | - | - | - | 0.12M | 0.19M |
| Total current assets | 0.33M | 0.50M | 0.32M | 0.26M | 0.31M |
| Net tangible assets | - | - | - | - | 0.07M |
| Short term investments | - | 0.02M | 0.02M | - | - |
| Net receivables | 0.02M | 0.07M | 0.04M | 0.02M | 0.00M |
| Inventory | 0.00M | 0.00M | 0.01M | 0.01M | 0.02M |
| Accounts payable | 0.11M | 0.15M | 0.10M | 0.03M | 0.01M |
| Accumulated other comprehensive income | 0.04M | 0.05M | 0.05M | -0.01M | -0.03M |
| Non currrent assets other | - | - | - | - | 0.00M |
| Non current assets total | 0.35M | 0.14M | 0.05M | 0.12M | 0.19M |
| Capital lease obligations | 0.28M | 0.11M | 0.04M | 0.10M | 0.17M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -0.11M | -0.01M | -0.01M | -0.06M |
| Change to liabilities | - | - | - | 0.00M | 0.01M |
| Total cashflows from investing activities | -0.01M | -0.11M | -0.00M | - | -0.06M |
| Net borrowings | -0.03M | 0.07M | -0.02M | -0.05M | -0.08M |
| Total cash from financing activities | -0.03M | 0.07M | -0.02M | -0.05M | -0.08M |
| Change to operating activities | - | - | - | - | 0.00M |
| Net income | -0.08M | 0.03M | -0.05M | -0.00M | 0.15M |
| Change in cash | -0.11M | 0.15M | 0.03M | -0.02M | 0.08M |
| Begin period cash flow | 0.40M | 0.25M | 0.21M | 0.23M | 0.16M |
| End period cash flow | 0.29M | 0.40M | 0.25M | 0.21M | 0.23M |
| Total cash from operating activities | -0.09M | 0.18M | 0.05M | 0.02M | 0.25M |
| Depreciation | 0.06M | 0.02M | 0.07M | 0.07M | 0.07M |
| Other cashflows from investing activities | -0.01M | 0.00M | 0.00M | - | - |
| Change to inventory | 0.00M | 0.00M | 0.00M | 0.01M | 0.02M |
| Change to account receivables | 0.06M | -0.02M | 0.03M | -0.02M | 0.01M |
| Other cashflows from financing activities | -0.03M | 0.07M | -0.00M | -0.04M | -0.07M |
| Change to netincome | - | - | - | 0.01M | -0.03M |
| Capital expenditures | 0.04M | 0.11M | 0.00M | 0.01M | 0.06M |
| Change in working capital | -0.05M | 0.14M | 0.03M | -0.05M | 0.04M |
| Other non cash items | -0.03M | -0.01M | 0.00M | -0.00M | -0.00M |
| Free cash flow | -0.14M | 0.08M | 0.04M | 0.01M | 0.19M |
Sector: Consumer Defensive Industry: Household & Personal Products
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DQWS DSwiss Inc |
- -% |
0.08 | - | - | 2.44 | 117.66 | 3.50 | 479.21 |
| PG Procter & Gamble Company |
-1.87 1.10% |
168.42 | 23.58 | 22.62 | 4.07 | 7.24 | 4.40 | 16.08 |
| LRLCF L'Oréal S.A |
5.90 1.22% |
490.20 | 41.14 | 34.25 | 6.52 | 8.59 | 6.67 | 27.76 |
| LRLCY L’Oreal Co ADR |
-1.21 1.25% |
95.84 | 32.44 | 25.64 | 5.16 | 6.03 | 4.79 | 19.51 |
| UL Unilever PLC ADR |
-1.23 1.90% |
63.30 | 21.53 | 16.39 | 2.66 | 7.29 | 2.77 | 12.45 |
DSwiss, Inc., a biotech nutraceutical company, provides healthcare, skincare, and personal care products in Malaysia, Singapore, Indonesia, Australia, Hong Kong, Taiwan, Macau, and China. It supplies health and beauty products, including weight management beverages, anti-aging creams, and immune system enhancers. The company also provides private label manufacturing services for nutraceutical and skincare/personal care ODM/OEM products; pet wellness supplements; and pet-care products, as well as medical consumable supplies, such as disposable stretcher cover and bedsheet, masks, body infrared thermometers, sanitizer, protective goggles, surgical gloves, isolation suit, industrial disinfectant, and protection surgical and medical gown. In addition, it offers OEM/ODM/OBM services, such as DSwiss quantum magnetic analyzer and DNA genotyping services; Eyecare; and biotechnology research channel services. DSwiss, Inc. was incorporated in 2015 and is headquartered in Kuala Lumpur, Malaysia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Ming Chia Leong | Founder, CEO, Pres, CFO, Sec., Treasurer & Director | 1982 |
| Ms. Natalie Low | Chief Product Specialist | NA |
| Ms. Queena Look | Chief Product Officer | NA |
| Mr. Ming Chia Leong | Founder, CEO, President, CFO, Secretary, Treasurer & Director | 1982 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.